Siemens Promotes Breast Cancer Awareness

Siemens HealthcareIn connection with October, the international breast cancer awareness month, Siemens has started a worldwide campaign to increase the public's understanding about breast cancer. Siemens is asking Internet users to upload their favorite portrait photo to a special web site. There all photos will be collected to create a virtual pink ribbon, the symbol of solidarity with breast cancer patients. As soon as the ribbon has traveled around the world once, Siemens will donate 50,000 Euros to the non-profit Susan G. Komen organization which is involved worldwide in the fight against breast cancer. In addition, Siemens has initiated a survey aimed at women in Brazil, China, Germany, India, Russia, the USA and other countries to determine the level of knowledge concerning breast cancer and early detection. The results of the survey will be published in the spring of 2011. Based on these results, Siemens will develop and distribute specific awareness material suitable for the countries included in the survey.

"More than ten percent of all women will be stricken with breast cancer during their life time. Despite this high number, large deficits exist in knowing about this disease and about early detection examinations," says Herrmann Requardt, CEO of Siemens Healthcare Sector. "The objective of our campaign is to heighten the awareness for this disease so that more women use the means available for early detection."

Siemens is therefore asking everyone who feels solidarity with breast cancer patients to post his/her favorite portrait photo to the Internet page www.siemens.com/pink. The photos will be arranged into a virtual pink ribbon that travels around the world. As soon as the ribbon has traveled once around the globe, Siemens will donate 50,000 Euros to the non-profit Susan G. Komen organization that finances projects for curing breast cancer and holds awareness campaigns.

As an additional step, an independent institute was requested to survey the knowledge of women aged 25-65 about breast cancer and early detection. The focus of this survey is on Brazil, Russia, India, China (BRIC states), the USA, Germany, Sweden and Austria. Siemens will inform the public about the results of the survey in the spring of 2011. In step with the information required from the women of these countries, Siemens will develop awareness and consultation material.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2009 (to September 30), the Sector posted revenue of 11.9 billion euros and profit of around 1.5 billion euros. For further information please visit: www.siemens.com/healthcare.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...